QA: Amicus Therapeutics INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2014_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 0.8879913506834505, 'aggregate_val': 122238000, 'exp_sum': 64745000, 'exp_to_value': {'remainder_Revenues': 64745000}}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 88,278,000
1 IntangibleAssetsNetIncludingGoodwill 34,613,000
2 PropertyPlantAndEquipmentNet 4,120,000
3 remainder_Assets 552,000
4 LiabilitiesCurrent 10,461,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,893,000
9 ResearchAndDevelopmentExpense 41,944,000
10 remainder_Expenses -667,000
11 remainder_Revenues 122,238,000
12 remainder_NetIncome 426,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 127,563,000
1 Liabilities 10,461,000
2 Expenses 60,170,000
3 Revenues 122,238,000
4 StockholdersEquity 117,102,000
5 NetIncome 62,494,000
6 ComprehensiveNetIncome 62,494,000
7 BaseVar 160,429,000
8 EconomicCapitalRatiobeforeLimitedLiability 4.60
9 EconomicCapitalRatio 4.86

Edgar->Model Mapping

Feature Distribution

Change over Time